Literature DB >> 16532400

GDF5 is a second locus for multiple-synostosis syndrome.

Katherine Dawson1, Petra Seeman, Eiman Sebald, Lily King, Matthew Edwards, John Williams, Stephan Mundlos, Deborah Krakow.   

Abstract

Multiple-synostosis syndrome is an autosomal dominant disorder characterized by progressive symphalangism, carpal/tarsal fusions, deafness, and mild facial dysmorphism. Heterozygosity for functional null mutations in the NOGGIN gene has been shown to be responsible for the disorder. However, in a cohort of six probands with multiple-synostosis syndrome, only one was found to be heterozygous for a NOGGIN mutation (W205X). Linkage studies involving the four-generation family of one of the mutation-negative patients excluded the NOGGIN locus, providing genetic evidence of locus heterogeneity. In this family, polymorphic markers flanking the GDF5 locus were found to cosegregate with the disease, and sequence analysis demonstrated that affected individuals in the family were heterozygous for a novel missense mutation that predicts an R438L substitution in the GDF5 protein. Unlike mutations that lead to haploinsufficiency for GDF5 and produce brachydactyly C, the protein encoded by the multiple-synostosis-syndrome allele was secreted as a mature GDF5 dimer. These data establish locus heterogeneity in multiple-synostosis syndrome and demonstrate that the disorder can result from mutations in either the NOGGIN or the GDF5 gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532400      PMCID: PMC1424701          DOI: 10.1086/503204

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite.

Authors:  J A McMahon; S Takada; L B Zimmerman; C M Fan; R M Harland; A P McMahon
Journal:  Genes Dev       Date:  1998-05-15       Impact factor: 11.361

2.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton.

Authors:  L J Brunet; J A McMahon; A P McMahon; R M Harland
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

3.  Mutations in CDMP1 cause autosomal dominant brachydactyly type C.

Authors:  A Polinkovsky; N H Robin; J T Thomas; M Irons; A Lynn; F R Goodman; W Reardon; S G Kant; H G Brunner; I van der Burgt; D Chitayat; J McGaughran; D Donnai; F P Luyten; M L Warman
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

4.  Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.

Authors:  J T Thomas; M W Kilpatrick; K Lin; L Erlacher; P Lembessis; T Costa; P Tsipouras; F P Luyten
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

5.  The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4.

Authors:  L B Zimmerman; J M De Jesús-Escobar; R M Harland
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

6.  Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development.

Authors:  S C Chang; B Hoang; J T Thomas; S Vukicevic; F P Luyten; N J Ryba; C A Kozak; A H Reddi; M Moos
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

7.  Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1.

Authors:  Georg C Schwabe; Seval Türkmen; Gundula Leschik; Sukru Palanduz; Brigitte Stöver; Timm O Goecke; Stefan Mundlos
Journal:  Am J Med Genet A       Date:  2004-02-01       Impact factor: 2.802

8.  A human chondrodysplasia due to a mutation in a TGF-beta superfamily member.

Authors:  J T Thomas; K Lin; M Nandedkar; M Camargo; J Cervenka; F P Luyten
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

9.  The mutational spectrum of brachydactyly type C.

Authors:  David B Everman; Cynthia F Bartels; Yue Yang; Niranjan Yanamandra; Frances R Goodman; J Roberto Mendoza-Londono; Ravi Savarirayan; Susan M White; John M Graham; Robert Peter Gale; Eva Svarch; William G Newman; Albert R Kleckers; Clair A Francomano; Vinukonda Govindaiah; Lalji Singh; Stuart Morrison; J Terrig Thomas; Matthew L Warman
Journal:  Am J Med Genet       Date:  2002-10-15

10.  Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily.

Authors:  E E Storm; T V Huynh; N G Copeland; N A Jenkins; D M Kingsley; S J Lee
Journal:  Nature       Date:  1994-04-14       Impact factor: 49.962

View more
  32 in total

1.  Identification of two novel mutations in the NOG gene associated with congenital stapes ankylosis and symphalangism.

Authors:  Akira Ganaha; Tadashi Kaname; Yukinori Akazawa; Teruyuki Higa; Ayano Shinjou; Kenji Naritomi; Mikio Suzuki
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

2.  A Novel GDF6 Mutation in a Family with Multiple Synostoses Syndrome without Hearing Loss.

Authors:  Ragnhild Drage Berentsen; Bjørn I Haukanes; Pétur B Júlíusson; Karen Rosendahl; Gunnar Houge
Journal:  Mol Syndromol       Date:  2018-08-15

Review 3.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

4.  Temtamy preaxial brachydactyly syndrome is caused by loss-of-function mutations in chondroitin synthase 1, a potential target of BMP signaling.

Authors:  Yun Li; Kathrin Laue; Samia Temtamy; Mona Aglan; L Damla Kotan; Gökhan Yigit; Husniye Canan; Barbara Pawlik; Gudrun Nürnberg; Emma L Wakeling; Oliver W Quarrell; Ingelore Baessmann; Matthew B Lanktree; Mustafa Yilmaz; Robert A Hegele; Khalda Amr; Klaus W May; Peter Nürnberg; A Kemal Topaloglu; Matthias Hammerschmidt; Bernd Wollnik
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

5.  Terminal osseous dysplasia with pigmentary defects (TODPD): Follow-up of the first reported family, characterization of the radiological phenotype, and refinement of the linkage region.

Authors:  Nicola Brunetti-Pierri; Ralph Lachman; Kwanghyuk Lee; Suzanne M Leal; Pasquale Piccolo; Ignatia B Van Den Veyver; Carlos A Bacino
Journal:  Am J Med Genet A       Date:  2010-07       Impact factor: 2.802

Review 6.  BMP signalling in skeletal development, disease and repair.

Authors:  Valerie S Salazar; Laura W Gamer; Vicki Rosen
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

7.  Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism.

Authors:  Wei Yang; Lihua Cao; Wenli Liu; Li Jiang; Miao Sun; Dai Zhang; Shusen Wang; Wilson H Y Lo; Yang Luo; Xue Zhang
Journal:  J Hum Genet       Date:  2008-02-19       Impact factor: 3.172

8.  Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.

Authors:  Frederick S Kaplan; Meiqi Xu; Petra Seemann; J Michael Connor; David L Glaser; Liam Carroll; Patricia Delai; Elisabeth Fastnacht-Urban; Stephen J Forman; Gabriele Gillessen-Kaesbach; Julie Hoover-Fong; Bernhard Köster; Richard M Pauli; William Reardon; Syed-Adeel Zaidi; Michael Zasloff; Rolf Morhart; Stefan Mundlos; Jay Groppe; Eileen M Shore
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN.

Authors:  K Lehmann; P Seemann; F Silan; T O Goecke; S Irgang; K W Kjaer; S Kjaergaard; M J Mahoney; S Morlot; C Reissner; B Kerr; A O M Wilkie; S Mundlos
Journal:  Am J Hum Genet       Date:  2007-06-08       Impact factor: 11.025

10.  Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.

Authors:  Petra Seemann; Anja Brehm; Jana König; Carsten Reissner; Sigmar Stricker; Pia Kuss; Julia Haupt; Stephanie Renninger; Joachim Nickel; Walter Sebald; Jay C Groppe; Frank Plöger; Jens Pohl; Mareen Schmidt-von Kegler; Maria Walther; Ingmar Gassner; Cristina Rusu; Andreas R Janecke; Katarina Dathe; Stefan Mundlos
Journal:  PLoS Genet       Date:  2009-11-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.